Reliva, an American CBD brand and subsidiary of the Edmonton-based Aurora Cannabis, has launched KG7, a new CBD product line developed for adult consumers with an active lifestyle.
KG7 and Reliva products are available for purchase online and in convenience stores across the U.S.
“We’re excited to introduce KG7 to the Reliva family of leading CBD products,” says Miguel Martin, CEO of Aurora Cannabis. “As part of Reliva’s portfolio expansion strategy, KG7 extends our brand into additional CBD market segments. With this product line, we expect to solidify Reliva’s position as the No. 1 CBD brand in brick and mortar channels.”
KG7’s lineup of CBD products includes pectin-based gummies made with natural flavours and colours, topical creams formulated with ingredients such as arnica and shea butter, and gluten-free CBD oil and drink mixes.
Standing by its zero-THC policy, each batch of KG7 is made with 100 per cent hemp-derived CBD isolate and is free of THC. All KG7 products are independent lab-verified and traceable to provide hemp products for physically active individuals.
Aurora serves both the medical and consumer markets, with a brand portfolio that includes Aurora, Aurora Drift, San Rafael ‘71, Daily Special, MedReleaf, CanniMed, Whistler, Reliva and KG7 CBD.
Find the latest must-read stories from the cannabis world at canadianevergreen.com, your go-to source for news, trends, products and lifestyle inspiration from the cannabis community and beyond. You can also follow us on Facebook and Instagram and Twitter.